Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: United Kingdom Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20131
20143
20153
20162
20174
20185
20196
202015
202114
202211
20236
20248
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca18
Hoffmann-La Roche7
Eli Lilly and Company6
Pfizer4
Genentech, Inc.3
Merck Sharp & Dohme LLC3
Seagen, a wholly owned subsidiary of Pfizer3
BicycleTx Limited2
European Organisation for Research and Treatment of Cancer - EORTC2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms84
Neoplasm Metastasis10
Neoplasms10
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms7
Ovarian Neoplasms7
Triple Negative Breast Neoplasms7
Prostatic Neoplasms6
Brain Neoplasms4
Breast Diseases4

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.